Showing results (2041-2050 of 2,463) with videos related to
Sort By:
Pageof 247
Physical Review Letters|August 11, 2001
Direct observation of a rho decay of the D13(1520) baryon resonanceW Langgärtner, J Ahrens, R Beck, et al.Nature Biotechnology|April 3, 2023
Epicardioid single-cell genomics uncovers principles of human epicardium biology in heart development and diseaseAnna B Meier, Dorota Zawada, Maria Teresa De Angelis, et al.JCO Precision Oncology|September 11, 2020
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIALJulia D Wulfkuhle, Christina Yau, Denise M Wolf, et al.American Journal of Medical Genetics. Part A|November 25, 2022
Genetic and phenotypic spectrum in the NONO-associated syndromic disorderFranziska Roessler, Anita E Beck, Ball Susie, et al.Molecular Metabolism|October 9, 2021
Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damageKarin J Bosma, Spencer R Andrei, Liora S Katz, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2013
Recommendations for returning genomic incidental findings? We need to talk!Wylie Burke, Armand H Matheny Antommaria, Robin Bennett, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapiesTam Binh V Bui, Denise M Wolf, Michael C Bruck, et al.Respiratory Medicine|June 30, 2018
Pulmonary interstitial glycogenosis - A systematic analysis of new casesE Seidl, J Carlens, S Reu, et al.Circulation|September 26, 2012
Ca2+/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac diseaseOlha M Koval, Jedidiah S Snyder, Roseanne M Wolf, et al.Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.Pageof 247